IL132085A0 - Compounds - Google Patents

Compounds

Info

Publication number
IL132085A0
IL132085A0 IL13208598A IL13208598A IL132085A0 IL 132085 A0 IL132085 A0 IL 132085A0 IL 13208598 A IL13208598 A IL 13208598A IL 13208598 A IL13208598 A IL 13208598A IL 132085 A0 IL132085 A0 IL 132085A0
Authority
IL
Israel
Prior art keywords
compounds
Prior art date
Application number
IL13208598A
Other languages
English (en)
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of IL132085A0 publication Critical patent/IL132085A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL13208598A 1997-04-09 1998-04-07 Compounds IL132085A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9701304A SE9701304D0 (sv) 1997-04-09 1997-04-09 Compounds
PCT/SE1998/000641 WO1998045294A1 (en) 1997-04-09 1998-04-07 Compounds

Publications (1)

Publication Number Publication Date
IL132085A0 true IL132085A0 (en) 2001-03-19

Family

ID=20406499

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13208598A IL132085A0 (en) 1997-04-09 1998-04-07 Compounds

Country Status (21)

Country Link
US (1) US6303613B1 (cs)
EP (1) EP0973772A1 (cs)
JP (1) JP2001519805A (cs)
KR (1) KR20010006143A (cs)
CN (1) CN1259131A (cs)
AU (1) AU7091098A (cs)
BR (1) BR9807950A (cs)
CA (1) CA2285388A1 (cs)
CZ (1) CZ355199A3 (cs)
EE (1) EE9900448A (cs)
HU (1) HUP0001865A2 (cs)
ID (1) ID23861A (cs)
IL (1) IL132085A0 (cs)
IS (1) IS5208A (cs)
NO (1) NO994900L (cs)
NZ (1) NZ338006A (cs)
PL (1) PL336141A1 (cs)
SE (1) SE9701304D0 (cs)
SK (1) SK128999A3 (cs)
TR (1) TR199902495T2 (cs)
WO (1) WO1998045294A1 (cs)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
SE9901530D0 (sv) * 1999-04-28 1999-04-28 Astra Pharma Prod Novel compounds
CO5261556A1 (es) 1999-12-08 2003-03-31 Pharmacia Corp Composiciones inhibidoras de ciclooxigenasa-2 que tiene rapido acceso de efecto terapeutico
CA2415697A1 (en) * 2000-07-13 2002-01-24 James C. Forbes Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain
NZ524252A (en) 2000-07-20 2004-03-26 Lauras As Cox-2 inhibitors for treating HIV and AIDS
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
BR0309259A (pt) * 2002-04-18 2005-02-09 Pharmacia Corp Terapia combinada para o tratamento de doença de parkinson com inibidores de ciclooxigenase-2 (cox 2)
WO2003088959A2 (en) * 2002-04-18 2003-10-30 Pharmacia Corporation Treatment of parkinson's disease with cyclooxygenase-2 (cox 2) inhibitor(s)
WO2004019986A1 (en) * 2002-08-29 2004-03-11 Schering Aktiengesellschaft Methods of treating acute respiratory distress syndrome
KR20050111318A (ko) * 2003-01-13 2005-11-24 다이노젠 파마세우티컬스, 인코포레이티드 기능성 장 질환을 치료하는 방법
WO2004101523A1 (en) * 2003-05-17 2004-11-25 Korea Research Institute Of Bioscience And Biotechnology Novel 2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same
KR100594377B1 (ko) * 2003-05-17 2006-06-30 한국생명공학연구원 항염증 활성을 갖는 신규 2-옥소-피페리딘 유도체(ⅰ)화합물, 이의 제조방법 및 이를 포함하는 염증 질환의치료를 위한 조성물
DE102005024012A1 (de) * 2005-05-20 2006-11-23 Grünenthal GmbH Verwendung von 2,5-disubstituierten Thiazol-4-on-Derivaten in Arzneimitteln
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
SI1924264T1 (sl) 2005-09-01 2013-12-31 F. Hoffmann-La Roche Ag Diaminopirimidini kot modulatorji p2x3 in p2x2/3
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
JP2011524896A (ja) 2008-06-18 2011-09-08 アストラゼネカ・アクチエボラーグ 呼吸器障害の処置用のベータ2−アドレナリン受容体アゴニストとして作用するベンズオキサジノン誘導体
IL305573A (en) 2021-03-15 2023-10-01 Saul Yedgar HYALURONIC ACID-CONJUGATED DIPALMITOYL PHOSPHATIDYL ETHANOLAMINE IN COMBINATION WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) FOR TREATING OR ALLEVIATING INFLAMMATORY DISEASES

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3403152A (en) * 1967-03-20 1968-09-24 Ciba Geigy Corp 1-aryl-4-imino-1, 2, 3, 4-tetrahydroquinazolines
US3483205A (en) * 1967-12-22 1969-12-09 Ciba Geigy Corp Bicyclic tetrahydropyrimidines
SE9703693D0 (sv) * 1997-10-10 1997-10-10 Astra Pharma Prod Novel combination

Also Published As

Publication number Publication date
PL336141A1 (en) 2000-06-05
NO994900D0 (no) 1999-10-08
HUP0001865A2 (hu) 2001-01-29
CZ355199A3 (cs) 2000-03-15
EE9900448A (et) 2000-04-17
US6303613B1 (en) 2001-10-16
JP2001519805A (ja) 2001-10-23
WO1998045294A1 (en) 1998-10-15
MX9909188A (en) 2001-07-01
CA2285388A1 (en) 1998-10-15
NO994900L (no) 1999-11-19
ID23861A (id) 2000-05-25
KR20010006143A (ko) 2001-01-26
BR9807950A (pt) 2000-03-08
SK128999A3 (en) 2000-05-16
NZ338006A (en) 2001-04-27
IS5208A (is) 1999-10-05
SE9701304D0 (sv) 1997-04-09
CN1259131A (zh) 2000-07-05
EP0973772A1 (en) 2000-01-26
TR199902495T2 (xx) 2000-07-21
AU7091098A (en) 1998-10-30

Similar Documents

Publication Publication Date Title
GB9714102D0 (en) Compounds
GB9715584D0 (en) Compounds
GB9710569D0 (en) Compounds
GB9708694D0 (en) Compounds
GB9708805D0 (en) Compounds
GB9709303D0 (en) Compounds
GB9711492D0 (en) Compounds
GB9712849D0 (en) Compounds
GB9704522D0 (en) Compounds
GB9702978D0 (en) Compounds
GB9704520D0 (en) Compounds
GB9705188D0 (en) Compounds
GB9704579D0 (en) Compounds
GB9716211D0 (en) Compounds
GB9704648D0 (en) Compounds
GB9708070D0 (en) Compounds
GB9707443D0 (en) Compounds
GB9709980D0 (en) Compounds
GB9702607D0 (en) Compounds
GB9715801D0 (en) Compounds
GB9705652D0 (en) Compounds
GB9708936D0 (en) Compounds
GB9706110D0 (en) Compounds
GB9705189D0 (en) Compounds
GB9702646D0 (en) Compounds